Exchange Traded Concepts’s AstraZeneca AZN Stock Holding History

Exchange Traded Concepts’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.07M	Buy	10,931 +1,112	+11%	+$209K	0.01%	707
2026 Q1	$1.94M	Buy	9,819 +2,107	+27%	+$406K	0.01%	623
2025 Q4	$1.42M	Buy	7,712 +24	+0.3%	+$4.21K	0.01%	674
2025 Q3	$1.18M	Sell	7,688 -465	-6%	-$70.4K	0.01%	717
2025 Q2	$1.14M	Sell	8,153 -4,832	-37%	-$677K	0.01%	641
2025 Q1	$1.91M	Sell	12,985 -505	-4%	-$73.1K	0.03%	384
2024 Q4	$1.77M	Buy	13,490 +1,006	+8%	+$141K	0.04%	414
2024 Q3	$1.95M	Buy	12,484 +5,658	+83%	+$913K	0.05%	338
2024 Q2	$1.06M	Buy	+6,826	New	+$1.03M	0.03%	427

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Exchange Traded Concepts's AZN Position: Q2 2026 in Review

Exchange Traded Concepts increased its AstraZeneca (AZN) stake by 11% in Q2 2026, buying an estimated $209K and bringing the position to 10,931 shares worth $2.07M. The position accounts for 0.01% of the portfolio, ranked #707.

Exchange Traded Concepts first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Exchange Traded Concepts held 10,931 shares of AstraZeneca worth $2.07M as of Q2 2026.
Exchange Traded Concepts bought 1,112 AstraZeneca shares in Q2 2026, an estimated $209K.
AstraZeneca made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #707 holding.
Exchange Traded Concepts first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.